Galabin, Geraldine .

HRN: 27-64-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2025
CEFOTAXIME 500MG (VIAL)
08/15/2025
08/21/2025
PO
500mg
Bid
Thickly
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines